company background image
543331 logo

Meghmani Organics BSE:543331 Stock Report

Last Price

₹82.00

Market Cap

₹20.8b

7D

-4.5%

1Y

-2.0%

Updated

09 May, 2024

Data

Company Financials

Meghmani Organics Limited

BSE:543331 Stock Report

Market Cap: ₹20.8b

543331 Stock Overview

Meghmani Organics Limited manufactures and sells pigments and agrochemicals in India and internationally.

543331 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends3/6

Meghmani Organics Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Meghmani Organics
Historical stock prices
Current Share Price₹82.00
52 Week High₹104.50
52 Week Low₹71.68
Beta-0.14
1 Month Change-1.49%
3 Month Change-0.29%
1 Year Change-2.01%
3 Year Changen/a
5 Year Changen/a
Change since IPO-13.23%

Recent News & Updates

Recent updates

Shareholder Returns

543331IN ChemicalsIN Market
7D-4.5%-5.6%-3.7%
1Y-2.0%11.2%38.4%

Return vs Industry: 543331 underperformed the Indian Chemicals industry which returned 14.8% over the past year.

Return vs Market: 543331 underperformed the Indian Market which returned 41.4% over the past year.

Price Volatility

Is 543331's price volatile compared to industry and market?
543331 volatility
543331 Average Weekly Movement6.4%
Chemicals Industry Average Movement6.4%
Market Average Movement6.6%
10% most volatile stocks in IN Market9.8%
10% least volatile stocks in IN Market4.2%

Stable Share Price: 543331 has not had significant price volatility in the past 3 months.

Volatility Over Time: 543331's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19861,994Ankit Patelmeghmani.com

Meghmani Organics Limited manufactures and sells pigments and agrochemicals in India and internationally. It offers green and blue pigments, which are used in printing inks, paints and coatings, and plastics. The company also provides agrochemical products comprising insecticides, which include cypermethrin, chlorpyriphos, alpha cypermethrin, permethrin, bifenthrin, lambda-cyhalothrin, deltamethrin, profenophos, acetamiprid, emamectin benzoate, and fipronil; herbicides, such as triclopyr butoxy ethyl ester, as well as 2,4-D acid tech, sodium salt WP/SP, and EsterTech; intermediates, including cypermethric acid chloride, meta phenoxy benzaldehyde, meta phenoxy benzyl alcohol, monochloroacetic acid, high trans cypermethric acid chloride, and high cis cypermethric acid chloride; and technical and formulations that are used in crop protection, veterinary, public health, and wood protection applications.

Meghmani Organics Limited Fundamentals Summary

How do Meghmani Organics's earnings and revenue compare to its market cap?
543331 fundamental statistics
Market cap₹20.82b
Earnings (TTM)-₹339.17m
Revenue (TTM)₹17.30b

1.2x

P/S Ratio

-61.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
543331 income statement (TTM)
Revenue₹17.30b
Cost of Revenue₹11.35b
Gross Profit₹5.95b
Other Expenses₹6.29b
Earnings-₹339.17m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 11, 2024

Earnings per share (EPS)-1.33
Gross Margin34.39%
Net Profit Margin-1.96%
Debt/Equity Ratio53.9%

How did 543331 perform over the long term?

See historical performance and comparison

Dividends

1.7%

Current Dividend Yield

15%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.